Ludwig-Maximilians-Universität München
print

Language Selection

Breadcrumb Navigation


Content

Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, Biotechnology

Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease (TransBioLine)

Project leader: Prof. Alexander Gerbes
Function of LMU Munich: Partner
Project participants: 27
Project launch: 1. February 2019, Project end: 31. January 2024, ( Duration: 60 months )
Total funding: 27 906 491 €
Program: Joint Technology Initiative - Innovative Medicines 2
Instrument/ funding scheme: Public-Private Partnerships (PPP)

Integration of Nano- and Biotechnology for beta-cell and islet Transplantation (iNanoBIT)

Project leader: Prof. Eckhard Wolf
Institute: Institut für Tierzucht
Function of LMU Munich: Partner
Project participants: 8
Project launch: 1. October 2017, Project end: 30. September 2022, ( Duration: 60 months )
Total funding: 6 999 997 €
Program: Leadership in Enabling and Industrial Technologies - Nanotechnologies, Advanced Materials and Production
Instrument/ funding scheme: Research and Innovation Action (RIA)